VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
40 hedge funds and large institutions have $71.2M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
40
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$161K | |
| 2 | +$155K | |
| 3 | +$122K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$90.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.3K |
Top Sellers
| 1 | -$905K | |
| 2 | -$505K | |
| 3 | -$362K | |
| 4 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$357K |
| 5 |
Jane Street
New York
|
-$331K |